Egr3 - early growth response 3 Gene
Also Known as EGR-3
Species: Rattus norvegicus
Summary
Predicted to enable DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in several processes, including cellular response to growth factor stimulus; endothelial cell migration; and positive regulation of endothelial cell proliferation. Predicted to act upstream of or within neuromuscular synaptic transmission; peripheral nervous system development; and regulation of T cell differentiation. Predicted to be located in nucleus and synapse. Orthologous to human EGR3 (early growth response 3). [provided by Alliance of Genome Resources, Apr 2022]
Egr3 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_017086.2 | NP_058782.1 | early growth response protein 3 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
early growth response protein 3 |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P2096 | Hexapeptide-11 | 99.77% | Unkown | |
| HY-RS04217 | EGR3 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS19895 | Egr3 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS26396 | Egr3 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-W106688 | Triisopropyl phosphate | Antagonist | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service